课题基金 / 基金详情

CLINICAL TRIAL: AGE-RELATED CHANGES IN NANOPARTICLE ALBUMIN BOUND (NAB)

CLINICAL TRIAL: AGE-RELATED CHANGES IN NANOPARTICLE ALBUMIN BOUND (NAB)
临床试验:纳米颗粒白蛋白结合的年龄相关变化
批准号:
7982088
负责人:
ARTI HURRIA
金额:
$18.44万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-11-30

项目摘要

项目成果

ARTI HURRIA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to measure blood levels of the drug nab-paclitaxel and to determine if a patient's age is associated with a change in the amount of nab-paclitaxel in the patient's body or the side effects. The nab-paclitaxel will be given on a weekly schedule for 3 out of 4 weeks.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Geriatric Oncology: Educating nurses to improve quality care
Geriatric Oncology: Educating nurses to improve quality care
Geriatric Oncology: Educating nurses to improve quality care
Physician Scientists in Aging: Developing and Activating Specialty Investigators
  • 批准号:
    9084490
  • 项目类别:
  • 资助金额:
    $4.99万
  • 财政年份:
    2014
  • 负责人:
    ARTI HURRIA
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: